Benchmarking the cost-effectiveness of interventions delaying diabetes: a simulation study based on NAVIGATOR data
OBJECTIVE To estimate using the UK Prospective Diabetes Study Outcomes Model Version 2 (UKPDS-OM2) the impact of delaying type 2 diabetes onset on costs and quality-adjusted life expectancy using trial participants who developed diabetes in the NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) study.
RESEARCH DESIGN AND METHODS We simulated the impact of delaying diabetes onset by 1–9 years, utilizing data from t...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- American Diabetes Association
- Copyright date:
- Rights statement:
- © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/license Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
- This is the accepted manuscript version of the article. The final version is available from American Diabetes Association at: https://doi.org/10.2337/dc20-0717
If you are the owner of this record, you can report an update to it here: Report update to this record